These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26536893)

  • 1. Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency.
    Mochel F; Hainque E; Gras D; Adanyeguh IM; Caillet S; Héron B; Roubertie A; Kaphan E; Valabregue R; Rinaldi D; Vuillaumier S; Schiffmann R; Ottolenghi C; Hogrel JY; Servais L; Roze E
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):550-3. PubMed ID: 26536893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triheptanoin improves brain energy metabolism in patients with Huntington disease.
    Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F
    Neurology; 2015 Feb; 84(5):490-5. PubMed ID: 25568297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
    Mochel F
    J Neurosci Res; 2017 Nov; 95(11):2236-2243. PubMed ID: 28688166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.
    Hainque E; Caillet S; Leroy S; Flamand-Roze C; Adanyeguh I; Charbonnier-Beaupel F; Retail M; Le Toullec B; Atencio M; Rivaud-Péchoux S; Brochard V; Habarou F; Ottolenghi C; Cormier F; Méneret A; Ruiz M; Doulazmi M; Roubergue A; Corvol JC; Vidailhet M; Mochel F; Roze E
    Orphanet J Rare Dis; 2017 Oct; 12(1):160. PubMed ID: 28969699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
    Pascual JM; Liu P; Mao D; Kelly DI; Hernandez A; Sheng M; Good LB; Ma Q; Marin-Valencia I; Zhang X; Park JY; Hynan LS; Stavinoha P; Roe CR; Lu H
    JAMA Neurol; 2014 Oct; 71(10):1255-65. PubMed ID: 25110966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency.
    Anheim M; Maillart E; Vuillaumier-Barrot S; Flamand-Rouvière C; Pineau F; Ewenczyk C; Riant F; Apartis E; Roze E
    J Neurol; 2011 Feb; 258(2):316-7. PubMed ID: 20830593
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and genetic characteristics of glucose transporter type 1 deficiency syndrome].
    Liu YY; Bao XH; Wang S; Fu N; Liu XY; Song FY; Yang YL; Wu Y; Zhang YH; Wu JX; Jiang YW; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):443-7. PubMed ID: 24120063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glut1 deficiency: when to suspect and how to diagnose?
    Verrotti A; D'Egidio C; Agostinelli S; Gobbi G
    Eur J Paediatr Neurol; 2012 Jan; 16(1):3-9. PubMed ID: 21962875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency.
    Afawi Z; Suls A; Ekstein D; Kivity S; Neufeld MY; Oliver K; De Jonghe P; Korczyn AD; Berkovic SF
    Epilepsia; 2010 Dec; 51(12):2466-9. PubMed ID: 21204808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively.
    Klepper J; Scheffer H; Leiendecker B; Gertsen E; Binder S; Leferink M; Hertzberg C; Näke A; Voit T; Willemsen MA
    Neuropediatrics; 2005 Oct; 36(5):302-8. PubMed ID: 16217704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding phenotype of GLUT1-deficiency syndrome.
    Brockmann K
    Brain Dev; 2009 Aug; 31(7):545-52. PubMed ID: 19304421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutation in a patient with late onset GLUT1 deficiency syndrome.
    Juozapaite S; Praninskiene R; Burnyte B; Ambrozaityte L; Skerliene B
    Brain Dev; 2017 Apr; 39(4):352-355. PubMed ID: 27927575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
    Becker F; Schubert J; Weckhuysen S; Suls A; Grüninger S; Korn-Merker E; Hofmann-Peters A; Sperner J; Cross H; Hallmann K; Elger CE; Kunz WS; Madeleyen R; Lerche H; Weber YG
    Epilepsy Res; 2015 Aug; 114():47-51. PubMed ID: 26088884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.
    Mullen SA; Suls A; De Jonghe P; Berkovic SF; Scheffer IE
    Neurology; 2010 Aug; 75(5):432-40. PubMed ID: 20574033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet.
    Friedman JR; Thiele EA; Wang D; Levine KB; Cloherty EK; Pfeifer HH; De Vivo DC; Carruthers A; Natowicz MR
    Mov Disord; 2006 Feb; 21(2):241-5. PubMed ID: 16149086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transporter type 1 deficiency due to SLC2A1 gene mutations--a rare but treatable cause of metabolic epilepsy and extrapyramidal movement disorder; own experience and literature review.
    Szczepanik E; Terczyńska I; Kruk M; Lipiec A; Dudko E; Tryfon J; Jurek M; Hoffman-Zacharska D
    Dev Period Med; 2015; 19(4):454-63. PubMed ID: 26982753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLUT1 deficiency syndrome: an update.
    Gras D; Roze E; Caillet S; Méneret A; Doummar D; Billette de Villemeur T; Vidailhet M; Mochel F
    Rev Neurol (Paris); 2014 Feb; 170(2):91-9. PubMed ID: 24269118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.
    Akman CI; Engelstad K; Hinton VJ; Ullner P; Koenigsberger D; Leary L; Wang D; De Vivo DC
    Ann Neurol; 2010 Jan; 67(1):31-40. PubMed ID: 20186957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
    Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
    Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood.
    Gramer G; Wolf NI; Vater D; Bast T; Santer R; Kamsteeg EJ; Wevers RA; Ebinger F
    Neuropediatrics; 2012 Jun; 43(3):168-71. PubMed ID: 22622956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.